Clinical Efficacy of Follitropin Alfa in GnRH-Antagonist Protocols: A Prospective Observational Phase IV Study on the Use of Biosimilar Follitropin Alfa r-hFSH in Assisted Reproductive Technology in a Routine Care Setting.

Assisted reproductive technology Biosimilar pharmaceuticals Follitropin alfa Gonadotropin-releasing hormone antagonist

Journal

Journal of reproduction & infertility
ISSN: 2228-5482
Titre abrégé: J Reprod Infertil
Pays: Iran
ID NLM: 101535586

Informations de publication

Date de publication:
Historique:
entrez: 27 5 2021
pubmed: 28 5 2021
medline: 28 5 2021
Statut: ppublish

Résumé

This phase IV routine care study evaluated ovarian responses when using a biosimilar follitropin alfa r-hFSH (Bemfola This multicenter, prospective, non-comparative, non-interventional study (Germany/Austria) was conducted with 885 women (Mean age of 34.0±4.4 years) for whom COS with Bemfola Among 986 ART cycles, COS was given for 9.9±1.8 days (First-day r-hFSH dose of 220.7±68.9 COS with Bemfola

Sections du résumé

BACKGROUND BACKGROUND
This phase IV routine care study evaluated ovarian responses when using a biosimilar follitropin alfa r-hFSH (Bemfola
METHODS METHODS
This multicenter, prospective, non-comparative, non-interventional study (Germany/Austria) was conducted with 885 women (Mean age of 34.0±4.4 years) for whom COS with Bemfola
RESULTS RESULTS
Among 986 ART cycles, COS was given for 9.9±1.8 days (First-day r-hFSH dose of 220.7±68.9
CONCLUSION CONCLUSIONS
COS with Bemfola

Identifiants

pubmed: 34041008
doi: 10.18502/jri.v22i2.5798
pii: JRI-22-116
pmc: PMC8143010
doi:

Types de publication

Journal Article

Langues

eng

Pagination

116-124

Informations de copyright

Copyright© 2021, Avicenna Research Institute.

Déclaration de conflit d'intérêts

Conflict of Interest The authors declare that they have no conflicts of interest.

Références

Hum Reprod. 2007 May;22(5):1348-52
pubmed: 17303632
JBRA Assist Reprod. 2017 Feb 1;21(1):49-53
pubmed: 28333033
Reprod Biomed Online. 2015 May;30(5):504-13
pubmed: 25735918
Hum Reprod. 2017 Dec 1;32(12):2485-2495
pubmed: 29121350
Expert Opin Drug Deliv. 2014 Dec;11(12):1859-64
pubmed: 25325925
Eur J Drug Metab Pharmacokinet. 2016 Jun;41(3):259-65
pubmed: 25633239
Fertil Steril. 2018 Jul 15;110(2):185-324.e5
pubmed: 30053940
Expert Opin Drug Deliv. 2018 Jun;15(6):549-558
pubmed: 29595399
Ultrasound Obstet Gynecol. 2015 Apr;45(4):377-93
pubmed: 25302750

Auteurs

Georg Griesinger (G)

Sektion Für Gynaekologische Endokrinologie und Reproduktionsmedizin, Klinik Für Frauenheilkunde & Geburtshilfe (Gynaekologie), Universitaetsklinikum Schleswig-Holstein-Campus Luebeck, Luebeck, Germany.

Thilo Schill (T)

MVZ Kinderwunschzentrum Langenhagen-Wolfsburg, Langenhagen, Germany.

Michael Sator (M)

Kinderwunsch im Zentrum GmbH, Tulln an der Donau, Austria.

Michael Schenk (M)

Das Kinderwunsch Institut Schenk GmbH, Dobl b. Graz, Austria.

Jan-Steffen Krüssel (JS)

Universitaeres interdisziplinäres Kinderwunschzentrum Duesseldorf (UniKiD), Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Duesseldorf, Duesseldorf, Germany.

Classifications MeSH